The predictive value of next generation sequencing for matching advanced hepatocellular carcinoma patients to targeted and immunotherapy
BackgroundTargeted and Immunotherapy has emerged as a new first-line treatment for advanced hepatocellular carcinoma (aHCC). To identify the appropriate targeted and immunotherapy, we implemented next generation sequencing (NGS) to provide predictive a…